HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rafael A Medina Selected Research

Antibodies

1/2022Assessment of Mutations Associated With Genomic Variants of SARS-CoV-2: RT-qPCR as a Rapid and Affordable Tool to Monitoring Known Circulating Variants in Chile, 2021.
1/2022Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines.
12/2021Preserved Omicron Spike specific antibody binding and Fc-recognition across COVID-19 vaccine platforms.
1/2021Evaluation of ELISA-Based Multiplex Peptides for the Detection of Human Serum Antibodies Induced by Zika Virus Infection across Various Countries.
1/2017Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins.
1/2016Infection in Health Personnel with High and Low Levels of Exposure in a Hospital Setting during the H1N1 2009 Influenza A Pandemic.
5/2013Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses.
6/2010Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus.
1/2010Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rafael A Medina Research Topics

Disease

13Infections
01/2022 - 02/2007
4COVID-19
11/2022 - 01/2022
4Human Influenza (Influenza)
11/2022 - 01/2010
2Convalescence
04/2022 - 09/2020
1Bacterial Pneumonia
01/2023
1Obesity
01/2023
1Orthomyxoviridae Infections
01/2023
1Superinfection
01/2023
1Pneumonia (Pneumonitis)
11/2022
1Bites and Stings (Sting)
01/2021
1Zika Virus Infection
01/2021
1Hantavirus Infections
03/2009

Drug/Important Bio-Agent (IBA)

9AntibodiesIBA
01/2022 - 01/2010
8VaccinesIBA
01/2023 - 01/2010
3Neutralizing AntibodiesIBA
11/2022 - 05/2021
3RNA (Ribonucleic Acid)IBA
01/2021 - 03/2009
2sinovac COVID-19 vaccineIBA
04/2022 - 05/2021
2BNT162 VaccineIBA
04/2022 - 05/2021
2Hemagglutinins (Hemagglutinin)IBA
01/2017 - 05/2013
1Oxygen (Dioxygen)IBA
01/2023
1AutoantibodiesIBA
11/2022
1Interferon Type IIBA
11/2022
1Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link
11/2022
1DNA-Directed RNA Polymerases (RNA Polymerase)IBA
01/2022
1Antiviral Agents (Antivirals)IBA
12/2021
1Aligeron (AS 2)IBA
01/2021
1Peptides (Polypeptides)IBA
01/2021
1Neuraminidase (Sialidase)IBA
01/2017
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
01/2017
1Proteins (Proteins, Gene)FDA Link
05/2013
1Oseltamivir (Tamiflu)FDA Link
11/2010
1Ribavirin (Virazole)FDA LinkGeneric
02/2007
1IntegrinsIBA
02/2007